These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4344846)

  • 41. [Modification of side effects from tuberculostatic agents by metoclopramide].
    Pollack KP
    Ther Ggw; 1967 Dec; 106(12):1606 passim. PubMed ID: 5622114
    [No Abstract]   [Full Text] [Related]  

  • 42. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 43. A triple regimen of streptomycin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 2.
    Oka S; Kayaba K
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):106-9. PubMed ID: 5525311
    [No Abstract]   [Full Text] [Related]  

  • 44. Capreomycin, ethambutol and rifampicin. Clinical experience in Manchester.
    Wilson TM
    Scand J Respir Dis Suppl; 1969; 69():33-42. PubMed ID: 4906372
    [No Abstract]   [Full Text] [Related]  

  • 45. Adverse drug reactions in TB therapy: risks and recommendations.
    Yoshikawa TT; Nagami PH
    Geriatrics; 1982 Jul; 37(7):61-8. PubMed ID: 7084671
    [No Abstract]   [Full Text] [Related]  

  • 46. [Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid)].
    Almansa de Cara S
    Rev Clin Esp; 1972 May; 125(4):353-6. PubMed ID: 5080180
    [No Abstract]   [Full Text] [Related]  

  • 47. [Duration of the after-control of the tuberculous patients following the termination of the treatment].
    Neumann G
    Wien Med Wochenschr; 1972 Dec; 122(51):764-8. PubMed ID: 4346497
    [No Abstract]   [Full Text] [Related]  

  • 48. Serum transaminase levels in pulmonary tuberculosis. Effect of triple treatment with 4-4 1-di-isoamyloxythiocarbanilide or PAS in combination with streptomycin and isoniazid.
    Ockerman PA; Ryde C
    Scand J Respir Dis; 1968; 49(1):35-41. PubMed ID: 5187250
    [No Abstract]   [Full Text] [Related]  

  • 49. [Liver damage from tuberculosis treatment].
    Keiner F
    Med Klin; 1981 Jun; 76(13):376-7. PubMed ID: 7254121
    [No Abstract]   [Full Text] [Related]  

  • 50. [Apoptosis-inducing action of antituberculosis drugs of the main group in vitro].
    Vasilyeva OA; Serebryakova VA; Urazova OI; Novitsky VV; Kononova TE; Naslednikova IO
    Antibiot Khimioter; 2010; 55(11-12):25-9. PubMed ID: 21574422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Some functional shifts occurring in the cardiovascular system, following a long-term antibacterial treatment].
    Reĭnval'd LA
    Probl Tuberk; 1970; 48(5):41-4. PubMed ID: 5449568
    [No Abstract]   [Full Text] [Related]  

  • 52. [Changing picture of tuberculosis during a decade].
    Tveit J
    Tidsskr Nor Laegeforen; 1971 Apr; 91(12):866-8. PubMed ID: 5554775
    [No Abstract]   [Full Text] [Related]  

  • 53. Drugs in the treatment of tuberculosis--1969.
    Beacham EG
    Johns Hopkins Med J; 1969 Nov; 125(5):286-90. PubMed ID: 5366128
    [No Abstract]   [Full Text] [Related]  

  • 54. [Intermittent 2-phase therapy using ethambutol-INH-streptomycin].
    Eule H; Fichtner K; Gross V; Sellau J
    Z Erkr Atmungsorgane Folia Bronchol; 1972 Apr; 136(2):139-57. PubMed ID: 4627225
    [No Abstract]   [Full Text] [Related]  

  • 55. Rifampin in original treatment of pulmonary tuberculosis. A United States Public Health Service cooperative therapy trial.
    Corpe R
    Bull Int Union Tuberc; 1972 Feb; 47():41-7. PubMed ID: 4562017
    [No Abstract]   [Full Text] [Related]  

  • 56. [Dynamics of various immunobiochemical and encephalographic indices during polychemotherapy of pulmonary tuberculosis patients].
    Sagalovich VIa; Medunitsyna ND; Andrzheiuk NI; Chelnokova NV; Sagalovich AV
    Probl Tuberk; 1982 Feb; (2):36-41. PubMed ID: 7063477
    [No Abstract]   [Full Text] [Related]  

  • 57. [The pseudorheumatism of antitubercular chemotherapy. Contribution to the study of the etiopathogenesis of neurotrophic rheumatism].
    Marche J; Chatard P
    Rev Rhum Mal Osteoartic; 1967; 34(1):16-33. PubMed ID: 4169554
    [No Abstract]   [Full Text] [Related]  

  • 58. [Proceedings: Significance and limits of controlled clinical research (in pulmonary tuberculosis)].
    Bignall JR
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):103-6. PubMed ID: 4588016
    [No Abstract]   [Full Text] [Related]  

  • 59. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparative study of biweekly streptomycin and isoniazid with daily P.A.S. and isoniazid regimens in the treatment of pulmonary tuberculosis.
    Mathur JB; Bahadur P; Agnihotri CB
    J Indian Med Assoc; 1967 Aug; 49(4):162-5. PubMed ID: 5594009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.